Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and fabry disease

American Journal of Cardiology

Volumn 109, Issue 4, 2012, Pages 587-593

  Namdar, Mehdi ^a,b   Steffel, Jan ^b   Jetzer, Sandra ^b   Schmied, Christian ^b   Hrlimann, David ^b   Camici, Giovanni G ^c   Bayrak, Fatih ^a   Ricciardi, Danilo ^a   Rao, Jayakeerthi Y ^a   De Asmundis, Carlo ^a   Chierchia, Gian Battista ^a   Sarkozy, Andrea ^a   Lscher, Thomas F ^b   Jenni, Rolf ^b   Duru, Firat ^b   Brugada, Pedro ^a  

^a Heart Rhythm Management Centre UZB   (Belgium)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYLOIDOSIS; AORTA STENOSIS; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FABRY DISEASE; FEMALE; HEART DISEASE; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AMYLOIDOSIS; ANALYSIS OF VARIANCE; AORTIC VALVE STENOSIS; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FABRY DISEASE; FEMALE; HEART DISEASES; HEART VENTRICLES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84856485169     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.09.052     Document Type: Article

References (30)

1. M. Sokolow, T.P. Lyon The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads Am Heart J 37 1949 161 186
2. A.L. Klein, L.K. Hatle, C.P. Taliercio, J.K. Oh, R.A. Kyle, M.A. Gertz, K.R. Bailey, J.B. Seward, A.J. Tajik Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis A Doppler echocardiography study Circulation 83 1991 808 816
3. J.S. Perkimki, M.J. Koistinen, S. Yli-Myry, H.V. Huikuri Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction J Am Coll Cardiol 26 1995 174 179
4. S. Ahnve Correction of the QT interval for heart rate: review of different formulas and the use of Bazett's formula in myocardial infarction Am Heart J 109 1985 568 574 (Pubitemid 16256710)
5. G.X. Yan, C. Antzelevitch Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome Circulation 98 1998 1928 1936 (Pubitemid 28509291)
6. R.B. Devereux, D.R. Alonso, E.M. Lutas, G.J. Gottlieb, E. Campo, I. Sachs, N. Reichek Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 57 1986 450 458 (Pubitemid 16119719)
7. D. Levy, D.D. Savage, R.J. Garrison, K.M. Anderson, W.B. Kannel, W.P. Castelli Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study Am J Cardiol 59 1987 956 960 (Pubitemid 17074242)
8. R. Jenni, A. Vieli, O. Hess, M. Anliker, H.P. Krayenbuehl Estimation of left ventricular volume from apical orthogonal 2-D echocardiograms Eur Heart J 2 1981 217 225 (Pubitemid 11092753)
9. R.J. Desnick, R. Brady, J. Barranger, A.J. Collins, D.P. Germain, M. Goldman, G. Grabowski, S. Packman, W.R. Wilcox Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy Ann Intern Med 138 2003 338 346 (Pubitemid 36205932)
10. M. Cybulla, K. Walter, H.P. Neumann, U. Widmer, M. Schrer, G. Sunder-Plassmann, T. Jansen, A. Rolfs, M. Beck [Fabry disease: demographic data since introduction of enzyme replacement therapy] Dtsch Med Wochenschr 132 2007 1505 1509 (Pubitemid 47121131)
11. P.M. Elliott, H. Kindler, J.S. Shah, B. Sachdev, O.E. Rimoldi, R. Thaman, M.T. Tome, W.J. McKenna, P. Lee, P.G. Camici Coronary microvascular dysfunction in male patients with AndersonFabry disease and the effect of treatment with alpha galactosidase A Heart 92 2006 357 360
12. S.F. Nagueh Fabry disease Heart 89 2003 819 820 (Pubitemid 36920791)
13. F. Weidemann, M. Niemann, F. Breunig, S. Herrmann, M. Beer, S. Strk, W. Voelker, G. Ertl, C. Wanner, J. Strotmann Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment Circulation 119 2009 524 529
14. P. Hoign, C.H. Attenhofer Jost, F. Duru, E.N. Oechslin, B. Seifert, U. Widmer, B. Frischknecht, R. Jenni Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy Int J Cardiol 111 2006 413 422 (Pubitemid 44205296)
15. M. Namdar, C. Kampmann, J. Steffel, D. Walder, J. Holzmeister, T.F. Lscher, R. Jenni, F. Duru PQ interval in patients with Fabry disease Am J Cardiol 105 2010 753 756
16. M. Namdar, J. Steffel, M. Vidovic, C.B. Brunckhorst, J. Holzmeister, T.F. Luscher, R. Jenni, F. Duru Electrocardiographic changes in early recognition of Fabry disease Heart 97 2011 485 490
17. M. Jastrzebski, B. Bacior, P.P. Dimitrow, K. Kawecka-Jaszcz Electrophysiological study in a patient with Fabry disease and a short PQ interval Europace 8 2006 1045 1047 (Pubitemid 44896798)
18. A. Aryana, M.A. Fifer, J.N. Ruskin, T. Mela Short PR interval in the absence of preexcitation: a characteristic finding in a patient with Fabry disease Pacing Clin Electrophysiol 31 2008 782 783 (Pubitemid 351749326)
19. C.M. Wolf, M. Arad, F. Ahmad, A. Sanbe, S.A. Bernstein, O. Toka, T. Konno, G. Morley, J. Robbins, J.G. Seidman, C.E. Seidman, C.I. Berul Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations Circulation 117 2008 144 154
20. J.B. Selvanayagam, P.N. Hawkins, B. Paul, S.G. Myerson, S. Neubauer Evaluation and management of the cardiac amyloidosis J Am Coll Cardiol 50 2007 2101 2110 (Pubitemid 350117349)
21. H.V. Desai, W.S. Aronow, S.J. Peterson, W.H. Frishman Cardiac amyloidosis: approaches to diagnosis and management Cardiol Rev 18 2010 1 11
22. J.B. Seward, G. Casaclang-Verzosa Infiltrative cardiovascular diseases: cardiomyopathies that look alike J Am Coll Cardiol 55 2010 1769 1779
23. S.R. Ommen, R.A. Nishimura, W.D. Edwards Fabry disease: a mimic for obstructive hypertrophic cardiomyopathy? Heart 89 2003 929 930 (Pubitemid 36920824)
24. S. Nakao, T. Takenaka, M. Maeda, C. Kodama, A. Tanaka, M. Tahara, A. Yoshida, M. Kuriyama, H. Hayashibe, H. Sakuraba An atypical variant of Fabry's disease in men with left ventricular hypertrophy N Engl J Med 333 1995 288 293
25. B. Murtagh, S.C. Hammill, M.A. Gertz, R.A. Kyle, A.J. Tajik, M. Grogan Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement Am J Cardiol 95 2005 535 537 (Pubitemid 40247559)
26. J.E. Rahman, E.F. Helou, R. Gelzer-Bell, R.E. Thompson, C. Kuo, E.R. Rodriguez, J.M. Hare, K.L. Baughman, E.K. Kasper Noninvasive diagnosis of biopsy-proven cardiac amyloidosis J Am Coll Cardiol 43 2004 410 415 (Pubitemid 38167701)
27. R. Wolk, S.M. Cobbe, M.N. Hicks, K.A. Kane Functional, structural, and dynamic basis of electrical heterogeneity in healthy and diseased cardiac muscle: implications for arrhythmogenesis and anti-arrhythmic drug therapy Pharmacol Ther 84 1999 207 231 (Pubitemid 29488552)
28. M. Zabel, P.R. Lichtlen, A. Haverich, M.R. Franz Comparison of ECG variables of dispersion of ventricular repolarization with direct myocardial repolarization measurements in the human heart J Cardiovasc Electrophysiol 9 1998 1279 1284 (Pubitemid 28565125)
29. R. Wolk, T. Mazurek, T. Lusawa, W. Wasek, J. Rezler Left ventricular hypertrophy increases transepicardial dispersion of repolarisation in hypertensive patients: a differential effect on QTpeak and QTend dispersion Eur J Clin Invest 31 2001 563 569 (Pubitemid 32642885)
30. R.H. Falk, A. Rubinow, A.S. Cohen Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities J Am Coll Cardiol 3 1984 107 113 (Pubitemid 14219960)